Pleasant Bay Capital Partners

Evia Bio is a life sciences innovation company focused on developing advanced cryopreservation technologies specifically designed for the cell therapy industry. The company specializes in all-natural cryopreservation solutions that aim to enhance the performance of cell and gene therapies. Utilizing a patented technology driven by an artificial intelligence algorithm, Evia Bio optimizes formulations to improve the post-thaw survival and functionality of cells utilized in therapeutics, fertility, and blood products. This innovative approach not only enhances the viability of target cell types but also activates epigenetic cryoprotective markers and mitigates cytoskeletal damage, thereby supporting cell therapy companies in creating effective and non-toxic therapeutic drugs.

Telemynd operates as a technology-enabled behavioral health company in the United States. It provides tele-psychiatry and tele-behavioral health services through licensed professionals using a cloud-based system, aiming to improve access to mental health care. The company also offers predictive analytics tools like PEER to assist clinicians in developing personalized treatment plans.

CueSquared is a developer of a mobile patient payment system designed specifically for the healthcare industry. The company's software enables healthcare providers to send and confirm patient statements and payments through SMS and email, facilitating efficient communication and payment processing. Additionally, CueSquared's system allows providers to track payments using graphs and analytics, which aids in revenue cycle management. The platform not only helps increase payment rates and reduce costs for healthcare providers but also offers patients a straightforward solution for viewing and managing their payment statements.

Lykan BioScience, LLC is a contract development and manufacturing services organization based in Phoenix, Arizona, established in 2017. The company specializes in providing outsourced end-to-end production and logistics solutions tailored for pharmaceutical and biotech companies. Its comprehensive service offerings include point-of-care solutions, tech transfer, manufacturing, operations access, quality program management, and supply chain management, with a particular focus on cell-based therapies. By integrating these services, Lykan BioScience aims to support clients in bringing innovative therapies to market efficiently and effectively.

Common Sensing, Inc. is a Cambridge, Massachusetts-based company that develops and manufactures innovative hardware and software solutions for individuals using injectable medications, particularly in diabetes care. The company is known for its flagship product, Gocap, a smart cap designed to transform conventional injector pens into connected devices that log insulin usage and provide valuable insights. The Gocap not only tracks dosing but also monitors temperature, sends reminders, and offers alerts, enhancing user engagement and medication adherence. Additionally, the accompanying Gocap app enables users to log glucose levels and meal entries, fostering better communication with healthcare providers and supporting informed decision-making. Founded in 2012, Common Sensing aims to improve health outcomes while reducing healthcare costs by facilitating education and communication for patients and their clinicians.

Scripta Insights offers a healthcare IT solution that analyzes pharmacy benefit manager transactions to identify and reduce overspending on prescription drugs. They serve self-insured employers, consultants, health plans, and members, delivering immediate savings through precise drug pricing.

Cuda Pharmaceuticals, LLC is a New York-based company founded in 2013 that specializes in the development and distribution of pharmaceutical products. The company focuses on a diverse portfolio that includes traditional generics, veterinary medicines, over-the-counter (OTC) products, new drug applications (NDA), and complex pharmaceuticals. By offering a variety of generic and specialty products, Cuda Pharmaceuticals aims to enhance the treatment options available to healthcare practitioners, ultimately improving patient care.

MedTouch LLC is a healthcare-focused digital agency that specializes in providing comprehensive digital strategy and technology solutions for healthcare organizations, including hospitals and health plans. Founded in 2004 and headquartered in Somerville, Massachusetts, with an additional office in Cedar Rapids, Iowa, MedTouch delivers services such as custom content creation, digital user experience and design, enterprise content management systems, and service line marketing. The company emphasizes real-time personalization to enhance patient engagement and streamline conversions, positioning its clients for long-term success. By integrating various components of digital strategy, MedTouch aims to create exceptional and coherent experiences for patients and members, supporting healthcare providers in navigating complex projects and achieving their goals effectively.